Brief: Lixte Biotechnology Announces Filing Of First Patent Application Resulting From Collaboration With The Netherlands Cancer Institute

NOMAD Power Solutions

12/01/2022 14:25

Jan 12 (Reuters) - 
    * LIXTE BIOTECHNOLOGY ANNOUNCES FILING OF FIRST PATENT
APPLICATION
RESULTING FROM COLLABORATION WITH THE NETHERLANDS CANCER
INSTITUTE AND THE ONCODE INSTITUTE TO IDENTIFY THE MOST
PROMISING DRUG COMBINATIONS FOR LEAD CLINICAL COMPOUND, LB-100

Source text for Eikon:  ID:nGNX7dhvgg 

 ((Reuters.Briefs@thomsonreuters.com;))